140 related articles for article (PubMed ID: 24300214)
1. Poly dimethyl diallyl ammonium coated CMK-5 for sustained oral drug release.
Zhang C; Zhao Q; Wan L; Wang T; Sun J; Gao Y; Jiang T; Wang S
Int J Pharm; 2014 Jan; 461(1-2):171-80. PubMed ID: 24300214
[TBL] [Abstract][Full Text] [Related]
2. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
Zhang Y; Zhi Z; Li X; Gao J; Song Y
Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
[TBL] [Abstract][Full Text] [Related]
3. Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol.
Sun L; Wang Y; Jiang T; Zheng X; Zhang J; Sun J; Sun C; Wang S
ACS Appl Mater Interfaces; 2013 Jan; 5(1):103-13. PubMed ID: 23237208
[TBL] [Abstract][Full Text] [Related]
4. Multilayer encapsulated mesoporous silica nanospheres as an oral sustained drug delivery system for the poorly water-soluble drug felodipine.
Hu L; Sun H; Zhao Q; Han N; Bai L; Wang Y; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():313-24. PubMed ID: 25492202
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of mesoporous carbon/lipid bilayer nanocomposites for improved oral delivery of the poorly water-soluble drug, nimodipine.
Zhang Y; Zhao Q; Zhu W; Zhang L; Han J; Lin Q; Ai F
Pharm Res; 2015 Jul; 32(7):2372-83. PubMed ID: 25609013
[TBL] [Abstract][Full Text] [Related]
6. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
Yi T; Wan J; Xu H; Yang X
Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
[TBL] [Abstract][Full Text] [Related]
7. A geometric pore adsorption model for predicting the drug loading capacity of insoluble drugs in mesoporous carbon.
Gao Y; Zhu W; Liu J; Di D; Chang D; Jiang T; Wang S
Int J Pharm; 2015 May; 485(1-2):25-30. PubMed ID: 25747453
[TBL] [Abstract][Full Text] [Related]
8. Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets.
Zhao Z; Gao Y; Wu C; Hao Y; Zhao Y; Xu J
Drug Dev Ind Pharm; 2016; 42(2):199-208. PubMed ID: 26114553
[TBL] [Abstract][Full Text] [Related]
9. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
10. Mesoporous carbon as a novel drug carrier of fenofibrate for enhancement of the dissolution and oral bioavailability.
Niu X; Wan L; Hou Z; Wang T; Sun C; Sun J; Zhao P; Jiang T; Wang S
Int J Pharm; 2013 Aug; 452(1-2):382-9. PubMed ID: 23688621
[TBL] [Abstract][Full Text] [Related]
11. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release.
Geng H; Zhao Y; Liu J; Cui Y; Wang Y; Zhao Q; Wang S
Int J Pharm; 2016 Aug; 510(1):184-94. PubMed ID: 27262268
[TBL] [Abstract][Full Text] [Related]
12. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
[TBL] [Abstract][Full Text] [Related]
13. Investigation of 3D ordered macroporous carbon with different polymer coatings and their application as an oral vaccine carrier.
Zhao Q; Zhang Q; Yue Y; Huang J; Di D; Gao Y; Shao X; Wang S
Int J Pharm; 2015 Jun; 487(1-2):234-41. PubMed ID: 25895720
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in vitro characterization of non-effervescent floating drug delivery system of poorly soluble drug, carvedilol phosphate.
Srikanth Meka V; Wee Liang VA; Dharmalingham SR; Sheshala R; Gorajana A
Acta Pharm; 2014 Dec; 64(4):485-94. PubMed ID: 25531788
[TBL] [Abstract][Full Text] [Related]
15. A novel solubility-modulated granules through porosity osmotic pump for controlled carvedilol delivery.
Song QL; Li P; Li YM
Pharm Dev Technol; 2012; 17(6):666-76. PubMed ID: 21486184
[TBL] [Abstract][Full Text] [Related]
16. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol.
Wang Y; Sun L; Jiang T; Zhang J; Zhang C; Sun C; Deng Y; Sun J; Wang S
Drug Dev Ind Pharm; 2014 Jun; 40(6):819-28. PubMed ID: 23594300
[TBL] [Abstract][Full Text] [Related]
17. Fabrication of novel GMO/Eudragit E100 nanostructures for enhancing oral bioavailability of carvedilol.
Patil SS; Roy K; Choudhary B; Mahadik KR
Drug Dev Ind Pharm; 2016 Aug; 42(8):1300-7. PubMed ID: 26651381
[TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration.
Venishetty VK; Chede R; Komuravelli R; Adepu L; Sistla R; Diwan PV
Colloids Surf B Biointerfaces; 2012 Jun; 95():1-9. PubMed ID: 22463845
[TBL] [Abstract][Full Text] [Related]
19. Solubility enhancement and physicochemical characterization of carvedilol solid dispersion with Gelucire 50/13.
Potluri RH; Bandari S; Jukanti R; Veerareddy PR
Arch Pharm Res; 2011 Jan; 34(1):51-7. PubMed ID: 21468915
[TBL] [Abstract][Full Text] [Related]
20. Electrospun polycaprolactone nanofibers as a potential oromucosal delivery system for poorly water-soluble drugs.
Potrč T; Baumgartner S; Roškar R; Planinšek O; Lavrič Z; Kristl J; Kocbek P
Eur J Pharm Sci; 2015 Jul; 75():101-13. PubMed ID: 25910438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]